Interesting Research Report on the Future of Hormone Replacement Therapy Market 2017-2023

Hormone Replacement Therapy Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Hormone Replacement Therapy Market by type (growth hormone replacement therapy, estrogen replacement therapy, thyroid hormone replacement therapy), by route of administration (oral, parenteral, transdermal) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Hormone Replacement Therapy Market it includes the five years Industry analysis and the 6 years annual forecast from 2017 to 2023. Some of the prominent participants in the Global Hormone Replacement Therapy Market are Amgen, Genentech, Novo Nordisk, Wyeth, Bayer, MED-EL, Eli Lily, Merck & Co., Mylan Laboratories, Pfizer and others. The global hormone replacement therapy market is projected to grow with a CAGR between 2.0% and 2.5% during 2017-2023.

Market Growth will be driven by Increasing in Incidence of Regularly Monitored Formulations, Technological Advancement in Drug Delivery Systems, and Growing Awareness among the Patients to Improve Overall Survival Rates

The global hormone replacement therapy market was sized over USD 5.97 billion in 2015. The global hormone replacement therapy market is projected to grow with a CAGR between 2.0% and 2.5% during 2017-2023. Increasing in incidence of regularly monitored formulations, technological advancement in drug delivery systems, growing awareness among the patients, reformulation of permitted drugs are the key factors driving the growth of global hormone replacement therapy market. Moreover, injectable hormones needs to be stored in cold conditions to preserve their efficiency, high cost of hormone replacement therapy treatment, and the side effect caused by hormonal replacement therapy are the key factors restraining the growth of this market. Increasing frequencies of hormonal imbalance disorders and rising geriatric population suffering from these diseases are likely to bring more opportunities to this market.      

Estrogen-Replacement Therapy Accounted For the Largest Market Share of 63.9% In 2015

The report segments the hormone replacement therapy market by type, by route of administration and by region. Market segmentation based on type includes growth hormone replacement therapy, estrogen replacement therapy and thyroid hormone replacement therapy. Moreover, estrogen-replacement therapy accounted for the largest market share of 63.9% in 2015. Oral, parenteral and transdermal is sub-segment of route of administration.

Americas was the Largest Market among the Geographies and Contributed Over 50.9% of the Revenue in the World Hormone Replacement Therapy Market In 2015

The report provides regional analysis covering geographies such as Americas, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023. Americas was the largest market among the geographies and contributed over 50.9% of the revenue in the world hormone replacement therapy market in 2015. Moreover, The U.S. was the largest contributor in terms of revenue in 2015 due to the awareness about the treatment procedures. Furthermore, Europe market is expected to grow steadily because of the increased in inactive lifestyles in the region. Asia Pacific is expected to grow at the highest CAGR over the forecast period due to increase in demand for hormone replacement therapies in countries such as Japan, Australia and China. ROW region is expected to grow gradually over the forecast period.

Major Key Players Mentioned in this Report

The companies covered in the report include Amgen, Genentech, Novo Nordisk, Wyeth, Bayer, MED-EL, Eli Lily, Merck & Co., Mylan Laboratories, Pfizer and others.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of hormone replacement therapy globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of hormone replacement therapy.Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the hormone replacement therapy market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market strategies of the leading players. This report will help manufacturers, suppliers and distributors of the hormone replacement therapy market to understand the present and future trends in this market and formulate their strategies accordingly.

Table of Contents:

1. Preface

1.1 Report Description

1.2 Research Methods

1.3 Research Approaches

2. Executive Summary

3. Global Hormone Replacement Therapy Market Overview

3.1 Introduction

3.2 Market Dynamics

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunities

3.3 Porter’s Five Forces Analysis

3.4 IGR – Growth Matrix Analysis

3.5 Competitive Landscape in the Hormone Replacement Therapy Market

4. Global Hormone Replacement Therapy Market by Type (USD Million) 2017 – 2023

4.1 Growth Hormone Replacement Therapy

4.2 Estrogen Replacement Therapy

4.3 Thyroid Hormone Replacement Therapy

5. Global Hormone Replacement Therapy Market by Route of Administration (USD Million) 2017 – 2023

5.1 Oral

5.2 Parenteral

5.3 Transdermal

6. Global Hormone Replacement Therapy Market Analysis, by Region (USD Million) 2017 – 2023

6.1 Americas

6.1.1 Americas Hormone Replacement Therapy Market by Type (USD Million)

6.1.2 Americas Hormone Replacement Therapy Market by Route of Administration (USD Million)

6.1.3 Americas Hormone Replacement Therapy Market by country (USD Million)

6.2 Europe

6.2.1 Europe Hormone Replacement Therapy Market by Type (USD Million)

6.2.2 Europe Hormone Replacement Therapy Market by Route of Administration (USD Million)

6.2.3 Europe Hormone Replacement Therapy Market by country (USD Million)

6.3 Asia-Pacific

6.3.1 Asia-Pacific Hormone Replacement Therapy Market by Type (USD Million)

6.3.2 Asia-Pacific Hormone Replacement Therapy Market by Route of Administration (USD Million)

6.3.3 Asia-Pacific Hormone Replacement Therapy Market by country (USD Million)

6.4 Rest of the World (RoW)

6.4.1 RoW Hormone Replacement Therapy Market by Type (USD Million)

6.4.2 RoW Hormone Replacement Therapy Market by Route of Administration (USD Million)

6.4.3 RoW Hormone Replacement Therapy Market by Sub-region (USD Million)

7. Company Profiles

7.1 Amgen

7.2 Genentech

7.3 Novo Nordisk, Wyeth

7.4 Bayer

7.5 MED-EL

7.6 Eli Lily, LLC

7.7 Merck & Co.

7.8 Mylan Laboratories

7.9 Pfizer

7.10 Novartis

7.11 Abbott Laboratories

Browse Detailed TOC, Description and Companies Mentioned in Report @

https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_hormone_replacement_therapy_market

Reset Password